Product Images Doxorubicin Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Doxorubicin Hydrochloride NDC 0143-9091 by Hikma Pharmaceuticals Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

structure - doxorubicin liquid novaplus 1

structure - doxorubicin   liquid   novaplus 1

fig. 1 - doxorubicin liquid novaplus 2

fig. 1 - doxorubicin   liquid   novaplus 2

The text is a figure showing a meta-analysis of disease-free survival with a hazard ratio, trial names, and a comparison between doxo based therapy and CMF. It also includes a boundary of non-inferiority with CMF.*

fig.2 - doxorubicin liquid novaplus 3

fig.2 - doxorubicin   liquid   novaplus 3

This appears to be a figure that shows a meta-analysis of Overall Survival, likely for cancer treatment. It includes different trials and the Hazard Ratio (a measure of treatment effectiveness) for each trial, along with confidence intervals. The figure compares Doxo-based treatments (used in six studies) to CMF treatments. The x-axis shows time, and the y-axis shows the Hazard Ratio.*

vial - doxorubicin liquid novaplus 4

vial - doxorubicin   liquid   novaplus 4

This is a description of a medication called DOXOrubicin. It is a sterile isotonic solution that is used for intravenous (IV) use only. The solution comes in a 5 mL single-dose vial and each mL contains 2mg of Doxorubicin HCI, sodium chloride, and water for injection. The usual dosage is included in the package insert. The medication is refrigerated and protected from light in the carton until it is time for use. The drug is preservative-free, and any unused portion should be discarded. The warning is provided that severe cellulitis, vesication, and tissue necrosis will occur if doxorubicin is extravasated during administration. This medication is distributed by Hikma Pharmaceuticals USA Inc. in Berkeley Heights, NJ.*

vial - doxorubicin liquid novaplus 5

vial - doxorubicin   liquid   novaplus 5

This is a description of a medication named Doxorubicin HCI, with a National Drug Code of 0143-9089-01, which comes in a 10mL Single Dose Vial that contains 2mg of Doxorubicin and other substances like Sodium Chloride and water. The medication should be stored in a refrigerator between 2°C to 8°C, protected from light until usage, and must be discarded if unused. The product is distributed by Hikma Pharmaceuticals USA under the brand novaplus™. The package of the product includes a warning about the risks of extravesation, which may cause severe cellulitis, vesiculation, and tissue necrosis. The image replacement text () includes some errors and typos.*

vial - doxorubicin liquid novaplus 6

vial - doxorubicin   liquid   novaplus 6

This text describes a medication named DOXOrubicin HCI Injection, USP, with a strength of 50mg per 25mL solution. The medication is stored in a 25mL vial and is intended for intravenous use only. The solution is sterile and isotonic and contains 2 mg Doxorubicin HCI, USP, Sodium Chloride, and Water for Injection, pH adjusted to 3 using Hydrochloric Acid. The medication should be stored in the refrigerator between 2°C to 8°C( 36°F to 46°F) and protected from light. Severe cellulitis, vesication, and tissue necrosis can occur if extravasation of the medication during administration happens. It is manufactured by THYMOORGAN PHARMAZIE GrabH, Germany, and distributed by Hikma Pharmaceuticals USA Inc. The package insert contains complete prescribing information, including the usual dosage.*

vial - doxorubicin liquid novaplus 7

vial - doxorubicin   liquid   novaplus 7

This is a pharmaceutical product - DOXOrubicin HCI Injection, USP, indicated for intravenous use only. Each 100 mL contains 200 mg Doxorubicin HCI USP and is provided in a sterile, isotonic solution. It is recommended to be stored in a refrigerator at 2° to 8°C and protected from light. Severe cellulitis, vesication, and tissue necrosis may occur if doxorubicin is extravasated during administration. It is manufactured by THYMOORGAN PHARMAZIE GmbH, Germany, and distributed by Hikma Pharmaceuticals USA Inc, Berkeley Heights, NJ 07922. Complete prescribing information can be found in the package insert. The NDC number for this product is 0143-8091-01.*

Representative Serialization Image - doxorubicin liquid novaplus 8

Representative Serialization Image - doxorubicin   liquid   novaplus 8

This is a product identification tag containing a Global Trade Item Number (GTIN) of 0301234567896, a serial number (SN) of 1234567890123, an expiration date (EXP) of MMMYYYY (month and year), and a lot number (LOT) of ABCDE12345.*

Representative Serialization Image - doxorubicin liquid novaplus 9

Representative Serialization Image - doxorubicin   liquid   novaplus 9

This text contains product and batch identification information. Specifically, the first section "T Lot" may indicate a lot number or tracking identification code. The following "ABCDE12345" may represent a product code or serial number, while "EXP MMMYYYY" likely represents an expiration date with month and year. The subsequent "GTIN 00301234567896" could signify a Global Trade Item Number, and "SN 12345678901234" may represent a unique serial number for the product. Based on this information, a product can be traced and identified for quality control or recall purposes.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.